4
audience entry points
Medical-reference first
The live site now combines core FKRP guides, a searchable evidence layer, glossary terms, and study tracking for patients, families, clinicians, physiotherapists, and researchers.
Launch readiness now depends on consistent metadata, cross-linking, and validation, not just publishing more pages.
4
audience entry points
10
paper and study records
6
glossary terms
Audience paths
Rapid orientation
Start with the disease overview, risk domains, and source-linked pages that frame FKRP care quickly.
Plain-language entry point
Understand the main terms, what multidisciplinary care means, and how to prepare for appointments.
Function and rehabilitation
See the practical FKRP context for mobility, fatigue, respiratory coordination, and team communication.
Evidence map
Use the site as a structured launch point into genotype, phenotype, monitoring, papers, and tracked studies.
Editorial baseline
Core reference pages include selected sources, review dates, and related links for deeper follow-up.
The site excludes private records and personal clinical documents by design.
Content is organized for families, clinicians, physiotherapists, and researchers, not one audience only.
Phase 2 delivers the core reference layer, while papers, trials, glossary terms, and search deepen the site later.
Core library
Foundational overview of the gene, protein, disease spectrum, and naming conventions.
Autosomal recessive inheritance, testing context, variant interpretation, and family implications.
High-level summary of muscle, motor, cardiac, respiratory, and broader phenotype patterns.
Multidisciplinary care framing for surveillance, coordination, and practical follow-up questions.
What is available now
The current public layer is designed to orient readers quickly while still exposing the evidence trail. Phase 5 focuses on quality, accessibility, and release readiness for that live set.
Curated FKRP summaries with practical takeaways, limitations, and topic-level indexing.
Phase 3Registry-linked study summaries and trial tracking with inclusion context and status notes.
Phase 3Organizations, registries, support links, and public guidance that belong alongside the core reference pages.